Combined PET/MRI: one step further in multimodality imaging

被引:99
作者
Sauter, Alexander W. [1 ,2 ]
Wehrl, Hans F. [1 ]
Kolb, Armin [1 ]
Judenhofer, Martin S. [1 ]
Pichler, Bernd J. [1 ]
机构
[1] Univ Tubingen, Lab Preclin Imaging & Imaging Technol, Werner Siemens Fdn, D-72076 Tubingen, Germany
[2] Univ Tubingen, Dept Diagnost & Intervent Radiol, D-72076 Tubingen, Germany
关键词
IN-VIVO DETECTION; ATTENUATION CORRECTION; TUMOR ANGIOGENESIS; SIMULTANEOUS PET; BLOOD-FLOW; CANCER; MRI; TOMOGRAPHY; EXPRESSION; BREAST;
D O I
10.1016/j.molmed.2010.08.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Given the need for sophisticated in vivo detection techniques to better characterize the cellular and subcellular processes in animals and humans, molecular imaging has become an important discipline. Techniques in molecular imaging have developed from stand alone modalities to multimodality methods. Among these, the combination of positron emission tomography (PET) and computed tomography (CT) is a successful imaging method and has become an important tool in clinical practice. Technological approaches that combine magnetic resonance imaging (MRI) with diffuse optical tomography (DOT), fluorescence tomography (FT) and PET have now been introduced. PET/MRI and the resulting combination of molecular, morphological and functional information will pave the way for a better understanding of physiological and disease mechanisms in preclinical and clinical settings.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 72 条
[1]   USE OF A GAMMA-RAY PINHOLE CAMERA FOR INVIVO STUDIES [J].
ANGER, HO .
NATURE, 1952, 170 (4318) :200-201
[2]   Combined Fluorescence and X-Ray Tomography for Quantitative In Vivo Detection of Fluorophore [J].
Barber, W. C. ;
Lin, Y. ;
Nalcioglu, O. ;
Iwanczyk, J. S. ;
Hartsough, N. E. ;
Gulsen, G. .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2010, 9 (01) :45-51
[3]  
BECQUEREL J, 1948, NATURE, V161, P609, DOI 10.1038/161609b0
[4]  
Bedrosian I, 1999, J NUCL MED, V40, P1143
[5]   Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man [J].
Beer, Ambros J. ;
Haubner, Roland ;
Sarbia, Mario ;
Goebel, Michael ;
Luderschmidt, Stephan ;
Grosu, Anca Ligia ;
Schnell, Oliver ;
Niemeyer, Markus ;
Kessler, Horst ;
Wester, Hans-Juergen ;
Weber, Wolfgang A. ;
Schwaiger, Markus .
CLINICAL CANCER RESEARCH, 2006, 12 (13) :3942-3949
[6]  
BELT JA, 1993, ADV ENZYME REGUL, V33, P235
[7]   In vivo detection and imaging of phosphatidylserine expression during programmed cell death [J].
Blankenberg, FG ;
Katsikis, PD ;
Tait, JF ;
Davis, RE ;
Naumovski, L ;
Ohtsuki, K ;
Kopiwoda, S ;
Abrams, MJ ;
Darkes, M ;
Robbins, RC ;
Maecker, HT ;
Strauss, HW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6349-6354
[8]  
Cannon WB, 1902, J MED RES, V7, P72
[9]  
Cherry SR, 2004, PHYS MED BIOL, V49, pR13, DOI 10.1088/0031-9155/49/3/R01
[10]   A fusion PET-MRI system with a high-resolution research tomograph-PET and ultra-high field 7.0 T-MRI for the molecular-genetic imaging of the brain [J].
Cho, Zang-Hee ;
Son, Young-Don ;
Kim, Hang-Keun ;
Kim, Kyoung-Nam ;
Oh, Se-Hong ;
Han, Jae-Yong ;
Hong, In-Ki ;
Kim, Young-Bo .
PROTEOMICS, 2008, 8 (06) :1302-1323